• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Edges Higher; Macy's Shares Jump

    12/11/23 2:26:20 PM ET
    $CI
    $COGT
    $GGE
    $HUM
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CI alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Monday.

    The Dow traded up 0.26% to 36,341.44 while the NASDAQ rose 0.12% to 14,421.98. The S&P 500 also rose, gaining, 0.30% to 4,618.11.

    Check This Out: This Analyst With 84% Accuracy Rate Sees More Than 7% Upside In Broadcom - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

     

    Leading and Lagging Sectors

     

    Industrials shares rose by 0.8% on Monday.

    In trading on Monday, communication services shares fell by 1.5%.

     

    Top Headline

     

    Macy's Inc (NYSE:M) shares jumped more than 20% on Monday following a report suggesting an investor group made a $5.8 billion buyout offer for the company.

     

    Equities Trading UP

     

    Pasithea Therapeutics Corp. (NASDAQ:KTTA) shares shot up 92% to $0.59 after the company announced preclinical results from two in vivo studies evaluating the antitumor efficacy of PAS-004 in NRAS mutation cancer xenograft models.

    Shares of MorphoSys AG (NASDAQ:MOR) got a boost, surging 24% to $8.76 as the company presented comprehensive results from the Phase 3 MANIFEST-2 study investigating pelabresib at 65th American Society of Hematology Annual Meeting.

    The Cigna Group (NYSE:CI) shares were also up, gaining 16% to $300.05. Cigna has withdrawn from its proposed merger with Humana Inc. (NYSE:HUM).

     

    Equities Trading DOWN

     

    Cogent Biosciences, Inc. (NASDAQ:COGT) shares dropped 54% to $3.9993 after the company reported initial data from its ongoing Phase 2 SUMMIT trial and data from Part 1 of its ongoing Phase 2 APEX clinical at ASH 2023.

    Shares of Green Giant Inc. (NASDAQ:GGE) were down 41% to $0.1510 after announcing a proposed public offering.

    Near Intelligence, Inc. (NASDAQ:NIR) was down, falling 39% to $0.0926. Near Intelligence filed for Chapter 11 protection and entered into agreement to sell its business.

    Also Check This Out: Alphabet, Best Buy And 2 Other Stocks Insiders Are Selling

     

    Commodities

    In commodity news, oil traded down 0.8% to $70.65 while gold traded down 1% at $1,994.40.

    Silver traded down 1% to $23.045 on Monday while copper fell 1.3% to $3.7810.

     

    Euro zone

     

    European shares closed mostly higher today. The eurozone’s STOXX 600 rose 0.30%, London’s FTSE 100 fell 0.13% while Spain’s IBEX 35 Index fell 0.25% The German DAX gained 0.21% French CAC 40 gained 0.33%, while Italy’s FTSE MIB Index rose 0.07%.

     

    Asia Pacific Markets

     

    Asian markets closed mostly higher on Monday, with Japan’s Nikkei 225 gaining 1.50%, Hong Kong’s Hang Seng Index falling 0.81% and China’s Shanghai Composite Index gaining 0.74%. India’s S&P BSE Sensex, meanwhile, rose 0.15%.

    Japan’s machine tool orders fell 13.6% year-over-year to JPY 115,884 million in November versus a 20.6% plunge in October. The business survey index of large manufacturing firms in Japan accelerated to 5.7% in the fourth quarter from 5.4% in the prior quarter.

    China's producer prices fell by 3.0% year-over-year in November versus a 2.6% decline in the previous month, while consumer prices fell by 0.5% year-over-year in November.

     

    Economics

     

    There were no major US economic releases Monday.

    Now Read This: Top 5 Tech And Telecom Stocks That Are Set To Fly In Q4

    Get the next $CI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CI
    $COGT
    $GGE
    $HUM

    CompanyDatePrice TargetRatingAnalyst
    Humana Inc.
    $HUM
    2/2/2026$174.00Equal-Weight → Underweight
    Morgan Stanley
    Macy's Inc
    $M
    1/14/2026$27.00Buy
    Jefferies
    Humana Inc.
    $HUM
    1/7/2026$290.00Overweight → Equal Weight
    Wells Fargo
    Macy's Inc
    $M
    12/10/2025Neutral
    Guggenheim
    Humana Inc.
    $HUM
    12/5/2025$313.00Hold → Buy
    Jefferies
    Macy's Inc
    $M
    12/4/2025$22.00 → $25.00Market Perform
    Telsey Advisory Group
    Macy's Inc
    $M
    11/28/2025$17.00 → $22.00Market Perform
    Telsey Advisory Group
    Cogent Biosciences Inc.
    $COGT
    11/10/2025$40.00Hold → Buy
    Stifel
    More analyst ratings

    $CI
    $COGT
    $GGE
    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Martin Aaron claimed no ownership of stock in the company (SEC Form 3)

    3 - HUMANA INC (0000049071) (Issuer)

    1/27/26 9:30:40 AM ET
    $HUM
    Medical Specialities
    Health Care

    Director Fairmount Funds Management Llc sold $127,400,000 worth of shares (3,500,000 units at $36.40) (SEC Form 4)

    4 - Cogent Biosciences, Inc. (0001622229) (Issuer)

    1/22/26 8:09:39 PM ET
    $COGT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & CEO Rechtin James A. converted options into 2,183 units of Humana Common and covered exercise/tax liability with 980 units of Humana Common (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    1/12/26 9:42:43 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $COGT
    $GGE
    $HUM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Steinman Lawrence bought $100,000 worth of shares (133,333 units at $0.75), increasing direct ownership by 201% to 199,691 units (SEC Form 4)

    4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)

    12/1/25 9:07:14 AM ET
    $KTTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Marques Tiago bought $25,000 worth of shares (33,333 units at $0.75), increasing direct ownership by 83% to 73,334 units (SEC Form 4)

    4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)

    12/1/25 8:56:56 AM ET
    $KTTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Dumesnil Simon bought $25,000 worth of shares (33,333 units at $0.75), increasing direct ownership by 1,333% to 35,833 units (SEC Form 4)

    4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)

    12/1/25 8:54:08 AM ET
    $KTTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CI
    $COGT
    $GGE
    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Humana Named KCTCS Education First Employer, Announces Humana Scholars Program for Nursing Students

    Humana is investing in a new program with Jefferson Community and Technical College to strengthen and support Kentucky's nursing workforce. In announcing the launch of the Humana Scholars program, Humana joins the Kentucky Community and Technical College System (KCTCS) network of Education First Employers, partnering with the system's Louisville campus, Jefferson. Humana is investing a total of $125,000 in the Humana Scholars program, which includes two components – a Scholarship Fund and a Student Support Fund – to help train and support a pipeline of skilled nurses. The program will offer both scholarships and help reduce barriers, like food insecurity or lack of transportation, for f

    2/5/26 10:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend

    Total revenues for 2025 increased 11% to $274.9 billionShareholders' net income for 2025 was $6.0 billion, or $22.18 per shareAdjusted income from operations1 for 2025 was $8.0 billion, or $29.84 per share2026 adjusted income from operations1 is projected to be at least $7.950 billion, or at least $30.25 per share2Board of Directors declared an increase in the quarterly dividend to $1.56 per shareBLOOMFIELD, Conn., Feb. 5, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported 2025 results, underscoring operational discipline and the strength of its complimentary portfolio of global health businesses.

    2/5/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    Humana Report Finds Value-Based Care Improves Outcomes for Medicare Advantage Members

    Medicare Advantage members in value-based care arrangements had 24.3% fewer inpatient hospital admissions than those in Original Medicare in 2024. Humana Medicare Advantage members receiving value-based care had 13.4% fewer emergency department visits and 7.6% fewer hospital admissions than members in non-value-based care arrangements. Medicare Advantage members receiving value-based care reported higher satisfaction with their care, including a 13-point higher Net Promoter Score than those using fee-for-service. Humana Inc. (NYSE:HUM), a health and well-being company focused on helping people live their healthiest lives, today released its latest Value-Based Care By the Numbers

    2/4/26 8:45:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $COGT
    $GGE
    $HUM
    SEC Filings

    View All

    SEC Form 144 filed by The Cigna Group

    144 - Cigna Group (0001739940) (Subject)

    2/6/26 2:05:58 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Cigna Group (0001739940) (Filer)

    2/5/26 6:15:54 AM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form S-8 filed by Pasithea Therapeutics Corp.

    S-8 - Pasithea Therapeutics Corp. (0001841330) (Filer)

    1/30/26 4:15:51 PM ET
    $KTTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CI
    $COGT
    $GGE
    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Humana downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Humana from Equal-Weight to Underweight and set a new price target of $174.00

    2/2/26 6:49:06 AM ET
    $HUM
    Medical Specialities
    Health Care

    Jefferies resumed coverage on Macy's with a new price target

    Jefferies resumed coverage of Macy's with a rating of Buy and set a new price target of $27.00

    1/14/26 8:43:49 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    Humana downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Humana from Overweight to Equal Weight and set a new price target of $290.00

    1/7/26 8:56:48 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $COGT
    $GGE
    $HUM
    Leadership Updates

    Live Leadership Updates

    View All

    VINCENT COUNTRY SAFE ZONE ACTIVITY DAY PRESENTED BY CIGNA HEALTHCARE DELIVERS SUPER BOWL WEEK FUN, NFL FLAG FOOTBALL, AND WELLNESS TO OAKLAND STUDENTS

    Corporate, Nonprofit, and Philanthropic Partners Collaborated to Provide Transformative Experiences and Lasting Resources at Burckhalter Elementary School OAKLAND, Calif., Feb. 3, 2026 /PRNewswire/ -- Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare, a flagship initiative of Love Thy Neighbor CDC co-founded by NFL Executive and Legend Troy Vincent, Sr. and his wife, author and chef Tommi A. Vincent, took place Tuesday, February 3, at Burckhalter Elementary School in Oakland, CA. The ninth annual event, themed Dreams Grow Here, delivered a full day of fun, food, wellness, and engaging sports activities, including NFL FLAG, for more than 200 Pre-K through fifth-grade studen

    2/3/26 8:17:00 PM ET
    $CI
    Medical Specialities
    Health Care

    Humana Announces Insurance Leadership Transition

    George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co

    12/16/25 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

    The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

    6/25/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $COGT
    $GGE
    $HUM
    Financials

    Live finance-specific insights

    View All

    The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend

    Total revenues for 2025 increased 11% to $274.9 billionShareholders' net income for 2025 was $6.0 billion, or $22.18 per shareAdjusted income from operations1 for 2025 was $8.0 billion, or $29.84 per share2026 adjusted income from operations1 is projected to be at least $7.950 billion, or at least $30.25 per share2Board of Directors declared an increase in the quarterly dividend to $1.56 per shareBLOOMFIELD, Conn., Feb. 5, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported 2025 results, underscoring operational discipline and the strength of its complimentary portfolio of global health businesses.

    2/5/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group's Fourth Quarter 2025 Earnings Release Details

    BLOOMFIELD, Conn., Jan. 13, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2025 financial results on Thursday, February 5, 2026, and will host a conference call the same day. Fourth quarter 2025 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call (888) 566-1889 (Domestic) (773) 799-3989 (International) Passcode: 02052026 Replay (866) 405-7290 (Domestic) (203) 369-0603 (

    1/13/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    Humana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026

    Humana Inc. (NYSE:HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on February 11, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 4Q25 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BIb3f01f81dd3b4f7cb8331d38dad89

    1/9/26 6:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $COGT
    $GGE
    $HUM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cogent Biosciences Inc.

    SC 13G/A - Cogent Biosciences, Inc. (0001622229) (Subject)

    11/14/24 7:59:55 PM ET
    $COGT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cogent Biosciences Inc.

    SC 13G/A - Cogent Biosciences, Inc. (0001622229) (Subject)

    11/14/24 5:47:15 PM ET
    $COGT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cogent Biosciences Inc.

    SC 13G/A - Cogent Biosciences, Inc. (0001622229) (Subject)

    11/14/24 4:05:10 PM ET
    $COGT
    Biotechnology: Pharmaceutical Preparations
    Health Care